Anthony D. Hill

Anthony D. Hill

Auto-generated profile, based on publicly available information

Anthony D. Hill

Schaller Research Group, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2011 in Neuron
Verified
Journal Article
Closed access
MLMaria K. Lehtinen
Maria K. Lehtinen
MZMauro W. Zappaterra
Mauro W. Zappaterra
XCXi Chen
Xi Chen
YYYawei J. Yang
Yawei J. Yang
AHAnthony D. Hill
Anthony D. Hill
CWChristopher A. Walsh
Christopher A. Walsh

9 December 2019 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
DODavid Ochoa
David Ochoa
AJAndrew Jarnuczak
Andrew Jarnuczak
CVCristina Viéitez
Cristina Viéitez
MGMaja Gehre
Maja Gehre
MSMargaret Soucheray
Margaret Soucheray
PBPedro Beltrao
Pedro Beltrao

1 April 2012 in Neuron
Verified
Journal Article
Closed access
APAnnapurna Poduri
Annapurna Poduri
GEGilad D. Evrony
Gilad D. Evrony
XCXuyu Cai
Xuyu Cai
PEPrincess Christina Elhosary
Princess Christina Elhosary
RBRameen Beroukhim
Rameen Beroukhim
CWChristopher A. Walsh
Christopher A. Walsh

1 December 2009 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
GMGaneshwaran H. Mochida
Ganeshwaran H. Mochida
MMMuhammad Mahajnah
Muhammad Mahajnah
AHAnthony D. Hill
Anthony D. Hill
LSLina Basel Salmon
Lina Basel Salmon
DGDanielle Gleason
Danielle Gleason
CWChristopher A. Walsh
Christopher A. Walsh

30 September 2012 in Nature Genetics
Verified
Journal Article
Open access
PDF file
GMGaneshwaran H Mochida
Ganeshwaran H Mochida
VGVijay S Ganesh
Vijay S Ganesh
MMMaria I de Michelena
Maria I de Michelena
HDHugo Dias
Hugo Dias
KAKutay D Atabay
Kutay D Atabay
CWChristopher A Walsh
Christopher A Walsh
Christopher Walsh and colleagues identify mutations in CHMP1A in human cerebellar hypoplasia and microcephaly. Cells lacking CHMP1A show decreased cell proliferation and decreased expression of BMI1, a negative regulator of stem cell proliferation. Charged multivesicular body protein 1A (CHMP1A; also known as chromatin-modifying protein 1A) is a member of the ESCRT-III (endosomal sorting complex required for transport-III) complex1,2 but is also suggested to localize to the nuclear matrix and regulate chromatin structure3. Here, we show that loss-of-function mutations in human CHMP1A cause reduced cerebellar size (pontocerebellar hypoplasia) and reduced cerebral cortical size (microcephaly). CHMP1A-mutant cells show impaired proliferation, with increased expression of INK4A, a negative regulator of stem cell proliferation. Chromatin immunoprecipitation suggests loss of the normal INK4A repression by BMI in these cells. Morpholino-based knockdown of zebrafish chmp1a resulted in brain defects resembling those seen after bmi1a and bmi1b knockdown, which were partially rescued by INK4A ortholog knockdown, further supporting links between CHMP1A and BMI1-mediated regulation of INK4A. Our results suggest that CHMP1A serves as a critical link between cytoplasmic signals and BMI1-mediated chromatin modifications that regulate proliferation of central nervous system progenitor cells.

27 May 2003 in Neurology
Verified
Journal Article
Closed access
PDF file
ARA. Rajab
A. Rajab
GMG. H. Mochida
G. H. Mochida
AHA. Hill
A. Hill
VGV. Ganesh
V. Ganesh
ABA. Bodell
A. Bodell
CWC. A. Walsh
C. A. Walsh
Objective: To describe a novel form of pontocerebellar hypoplasia (PCH) and map its genetic locus. Background: PCH is a heterogeneous group of disorders that are characterized by abnormally small cerebellum and brainstem. Autosomal recessive inheritance has been implied in many cases, but no genetic loci have been mapped to date. Methods: The authors studied a consanguineous family from the Sultanate of Oman with three siblings with a novel form of PCH. The authors performed clinical studies and linkage analysis of this pedigree. Results: The clinical features of the affected children include developmental delay, progressive microcephaly with brachycephaly, seizures during the first year of life, hypotonia with hyperreflexia, short stature, and optic atrophy. Imaging studies showed a small pons and cerebellum, prominent sulci and lateral ventricles, and decreased cerebral white matter volume. A lack of dyskinesias distinguishes this pedigree from PCH type 2. Genetic studies of this family revealed evidence of significant linkage to chromosome 7q11-21 (maximum multipoint lod score 3.23). Conclusions: This pedigree represents a novel form of autosomal recessive PCH, which the authors propose to call cerebellar atrophy with progressive microcephaly (CLAM). This disorder maps to chromosome 7q11-21, and this locus was named CLAM. This report represents the first identification of a genetic locus for PCH.